title: Similar concerns. Safety, costs among the issues to be weighed as FDA grapples with crafting an approval process for generic versions of biological medicines.
authors.forename: Rich
authors.initials: R
authors.lastname: Daly
mesh_terms: D001688:Biological Products / Q000592:standards*; D017277:Drug Approval / Q000331:legislation & jurisprudence* / Q000379:methods; D064420:Drug-Related Side Effects and Adverse Reactions; D016568:Drugs, Generic / Q000592:standards*; D033161:Government Regulation; D006801:Humans; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D001688:Biological Products; D016568:Drugs, Generic